Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 42

1.

Elevated Markers of Vascular Remodeling and Arterial Stiffness Are Associated With Neurocognitive Function in Older HIV+ Adults on Suppressive Antiretroviral Therapy.

Montoya JL, Iudicello J, Fazeli PL, Hong S, Potter M, Ellis RJ, Grant I, Letendre SL, Moore DJ; HIV Neurobehavioral Research Program (HNRP) Group..

J Acquir Immune Defic Syndr. 2017 Feb 1;74(2):134-141. doi: 10.1097/QAI.0000000000001230.

PMID:
27828873
2.

Increased Immune Activation and Exhaustion in HIV-infected Youth.

Eckard AR, Rosebush JC, Lee ST, O'Riordan MA, Habib JG, Daniels JE, Labbato D, Uribe-Leitz M, Chahroudi A, McComsey GA.

Pediatr Infect Dis J. 2016 Dec;35(12):e370-e377.

PMID:
27626922
3.
4.

Screening for Neurocognitive Impairment in HIV-Infected Individuals at First Contact after HIV Diagnosis: The Experience of a Large Clinical Center in Northern Italy.

Focà E, Magro P, Motta D, Compostella S, Casari S, Bonito A, Brianese N, Ferraresi A, Rodari P, Pezzoli MC, Quiros-Roldan E, Castelli F.

Int J Mol Sci. 2016 Mar 24;17(4):434. doi: 10.3390/ijms17040434.

5.

Compensatory activation in fronto-parietal cortices among HIV-infected persons during a monetary decision-making task.

Meade CS, Cordero DM, Hobkirk AL, Metra BM, Chen NK, Huettel SA.

Hum Brain Mapp. 2016 Jul;37(7):2455-67. doi: 10.1002/hbm.23185.

PMID:
27004729
6.

Application of brain multi-b-value diffusion-weighted imaging (DWI) in adolescent orphans from AIDS families.

Jiang DZ, Zhong Y, Zhou DY, Wu WQ, Wu GY, Quan H.

Br J Radiol. 2016;89(1060):20150732. doi: 10.1259/bjr.20150732.

PMID:
26892165
7.

Liver Fibrosis Linked to Cognitive Performance in HIV and Hepatitis C.

Valcour VG, Rubin LH, Obasi MU, Maki PM, Peters MG, Levin S, Crystal HA, Young MA, Mack WJ, Cohen MH, Pierce CB, Adimora AA, Tien PC; Womenʼs Interagency HIV Study Protocol Team..

J Acquir Immune Defic Syndr. 2016 Jul 1;72(3):266-73. doi: 10.1097/QAI.0000000000000957.

PMID:
26885801
8.

Immunoinflammatory diseases of the central nervous system - the tale of two cytokines.

Hofer MJ, Campbell IL.

Br J Pharmacol. 2016 Feb;173(4):716-28. doi: 10.1111/bph.13175. Review.

PMID:
25917268
9.

Mechanisms of HIV-1 Tat neurotoxicity via CDK5 translocation and hyper-activation: role in HIV-associated neurocognitive disorders.

Fields JA, Dumaop W, Crews L, Adame A, Spencer B, Metcalf J, He J, Rockenstein E, Masliah E.

Curr HIV Res. 2015;13(1):43-54. Review.

10.

Independent effects of HIV infection and cocaine dependence on neurocognitive impairment in a community sample living in the southern United States.

Meade CS, Towe SL, Skalski LM, Robertson KR.

Drug Alcohol Depend. 2015 Apr 1;149:128-35. doi: 10.1016/j.drugalcdep.2015.01.034.

11.

Association between brain volumes and HAND in cART-naïve HIV+ individuals from Thailand.

Heaps JM, Sithinamsuwan P, Paul R, Lerdlum S, Pothisri M, Clifford D, Tipsuk S, Catella S, Busovaca E, Fletcher JL, Raudabaugh B, Ratto-Kim S, Valcour V, Ananworanich J; SEARCH 007/011 study groups..

J Neurovirol. 2015 Apr;21(2):105-12. doi: 10.1007/s13365-014-0309-8.

12.

Evaluation of emotion processing in HIV-infected patients and correlation with cognitive performance.

Baldonero E, Ciccarelli N, Fabbiani M, Colafigli M, Improta E, D'Avino A, Mondi A, Cauda R, Di Giambenedetto S, Silveri MC.

BMC Psychol. 2013 Feb 27;1(1):3. doi: 10.1186/2050-7283-1-3.

13.

Associations between brain microstructures, metabolites, and cognitive deficits during chronic HIV-1 infection of humanized mice.

Boska MD, Dash PK, Knibbe J, Epstein AA, Akhter SP, Fields N, High R, Makarov E, Bonasera S, Gelbard HA, Poluektova LY, Gendelman HE, Gorantla S.

Mol Neurodegener. 2014 Dec 18;9:58. doi: 10.1186/1750-1326-9-58.

14.

Abdominal obesity contributes to neurocognitive impairment in HIV-infected patients with increased inflammation and immune activation.

Sattler FR, He J, Letendre S, Wilson C, Sanders C, Heaton R, Ellis R, Franklin D, Aldrovandi G, Marra CM, Clifford D, Morgello S, Grant I, McCutchan JA; CHARTER Group..

J Acquir Immune Defic Syndr. 2015 Mar 1;68(3):281-8. doi: 10.1097/QAI.0000000000000458.

15.

Role of the immune system in HIV-associated neuroinflammation and neurocognitive implications.

Hong S, Banks WA.

Brain Behav Immun. 2015 Mar;45:1-12. doi: 10.1016/j.bbi.2014.10.008. Review.

16.

Gap junctions and hemichannels composed of connexins: potential therapeutic targets for neurodegenerative diseases.

Takeuchi H, Suzumura A.

Front Cell Neurosci. 2014 Sep 2;8:189. doi: 10.3389/fncel.2014.00189. Review.

17.

Development of HIV reservoir targeted long acting nanoformulated antiretroviral therapies.

Edagwa BJ, Zhou T, McMillan JM, Liu XM, Gendelman HE.

Curr Med Chem. 2014;21(36):4186-98. Review.

18.

HIV-1 transgenic rats display alterations in immunophenotype and cellular responses associated with aging.

Abbondanzo SJ, Chang SL.

PLoS One. 2014 Aug 15;9(8):e105256. doi: 10.1371/journal.pone.0105256.

19.

Value of perfusion-weighted MR imaging in the assessment of early cerebral alterations in neurologically asymptomatic HIV-1-positive and HCV-positive patients.

Bladowska J, Knysz B, Zimny A, Małyszczak K, Kołtowska A, Szewczyk P, Gąsiorowski J, Furdal M, Sąsiadek MJ.

PLoS One. 2014 Jul 11;9(7):e102214. doi: 10.1371/journal.pone.0102214.

20.

Host genetic factors predisposing to HIV-associated neurocognitive disorder.

Kallianpur AR, Levine AJ.

Curr HIV/AIDS Rep. 2014 Sep;11(3):336-52. doi: 10.1007/s11904-014-0222-z. Review.

Items per page

Supplemental Content

Support Center